Tarsus Pharmaceuticals: Strong Execution In Eye Disease Treatment

1 IF D H HT T 100 - 100 1 i T 1 Pgiam/iStock via Getty Images Tarsus Pharma (NASDAQ:TARS) has an approved drug for a mite infestation eye disease called Demodex blepharitis and multiple late-stage assets in its pipeline. Its key molecule is called lotilaner, an antiparasitic widely used in veterinary medicine for the treatment of ticks, mites and other infestations. It's available in oral tablet forms and is known to be effective in animals. Tarsus has 3 product candidates, all of which are various formulat ...